Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand
- Conditions
- COVID-19
- Registration Number
- NCT05328479
- Lead Sponsor
- Mahidol University
- Brief Summary
The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.
- Detailed Description
The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5181
- patient with infected with the novel coronavirus disease 2019 (COVID-19) who has been end of self-quarantine at Siriraj Hospital more than 21 days.
- Thai nationality, able to read and write Thai language
- able to use telephone and line to communicate
- people who received additional vaccination after leaving quarantine before the day of the immunization test
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti-SARS-CoV-2 RBD IgG Baseline Anti-RBD IgG (BAU/mL)
Cycle threshold of the first PCR test Baseline Cycle threshold (Ct)
Anti-SARS-CoV-2 NP Baseline Anti-SARS-CoV-2 NP (PRNT50 titer)
- Secondary Outcome Measures
Name Time Method Type of vaccine injection Baseline Type of vaccine injection
Number of vaccine injection Baseline Number of vaccine injection
Trial Locations
- Locations (1)
Faculty of Medicine Siriraj Hospital, Mahidol University
🇹ðŸ‡Bangkok Noi, Bangkok, Thailand